Ikarian Capital, LLC Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $7.63 Million - $10.9 Million	-119,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $7.75 Million - $11.7 Million	119,100 New	119,100 $10.2 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $2.95 Million - $3.9 Million	-50,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $8.7 Million - $22.3 Million	-300,000 Reduced 85.71%	50,000 $3.66 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $4.13 Million - $8.59 Million	150,000 Added 75.0%	350,000 $11.9 Million
Q4 2019 Jan 31, 2020	BUY	$40.86 - $57.65 $8.17 Million - $11.5 Million	200,000 New	200,000 $10.9 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.